Introducing 3-Amino-4-Iodopyridine: Precision for Advanced Chemical Synthesis

A Fresh Perspective on Pyridine Derivatives

Synthetic chemistry stands on the shoulders of reliable building blocks. Over the years, we’ve witnessed first-hand how the introduction of specialty pyridine derivatives like 3-Amino-4-Iodopyridine drives innovation. Our own manufacturing facilities have produced this compound at scale to support researchers and process chemists who tackle increasingly complex synthetic targets. With its unique combination of an amino and iodine group on the pyridine core, this molecule presents distinct advantages not found in common halopyridines or simple aminopyridines.

Model and Identity Grounded in Purpose

We offer 3-Amino-4-Iodopyridine (CAS 760207-93-4) with a deep understanding of what the market actually demands. The product appears as an off-white to light brown solid, produced in batches that meet or exceed ≥98% purity by HPLC assay. Through years of continuous feedback from pharmaceutical and agrochemical producers, we have tuned our synthesis to control isomer ratios and minimize impurities such as other halogenated by-products or residual solvents. Each batch is tailored to support scale-up in medicinal chemistry and process research.

The Story Behind the Chemistry

Let’s talk chemistry. The iodine atom at the 4-position offers a convenient handle for Suzuki, Sonogashira, and Buchwald-Hartwig couplings—reactions forming the backbone of combinatorial methods in drug discovery. Chemists can quickly introduce a variety of complex side chains without laborious steps. Traditional iodopyridines lack an amino group, which leaves researchers scrambling to introduce new functionality later in the synthesis. Our material places both reactive sites on a single, compact scaffold. This gives direct access to N-arylated, N-alkylated, or even fused heterocyclic frameworks, all without the need for harsh conditions or excess reagents.

Practical Use and Handling Insights

As manufacturers, we see the daily routine of scaling up from milligrams to multi-kilogram lots. Customers in pharmaceutical development told us that batch consistency is their prime concern. Any variance in melting point, color, or trace impurities may trigger costly batch failures downstream. Our technicians follow rigorous QC procedures, including GC-MS, HPLC, and NMR verification.

We package the compound in moisture-resistant liners, based on input from partners who’ve experienced product clumping or degradation. While some distributors repack bulk powders, sometimes risking cross-contamination, we handle all post-synthesis isolation, drying, and quality assessments in-house. This approach provides traceability from raw materials through finished product, and a clear chain of custody for regulatory submissions.

Why 3-Amino-4-Iodopyridine Matters

Many customers ask: Why use a pyridine with both amino and iodine substituents? The advantage lies in reaction flexibility. A more common compound like 4-Iodopyridine often requires extra functionalization steps—slowing discovery timelines and increasing material waste. Simple aminopyridines lack the direct halogen handle needed for rapid C–C or C–N bond formation. Using a bifunctional pyridine saves on step count and opens creative routes to new analogues.

Medicinal chemists rely on this flexibility when exploring structure-activity relationships (SAR). For example, the electron-donating nature of the amino group modulates pyridine’s reactivity, making it suited for coupling with diverse acids, amines, or boronic acids. The presence of iodine, as opposed to chloro or bromo analogues, confers higher coupling efficiency, leading practitioners to favor this product in high-value syntheses. We have supplied multi-kilogram batches for several patent-backed pharmaceutical intermediates, and feedback from process teams confirms the reliability of our material at both small and large scale.

Addressing Problems with Comparative Chemistry

Every synthetic chemist wrestles with route selection. Choosing between different halogen or amino placement can make or break a process. In the early 2010s, we fielded repeated calls for custom aminopyridines bearing unusual substitution patterns, often with limited stability or poor shelf life. Our chemists took up the challenge of producing 3-Amino-4-Iodopyridine with stability adequate for long-term storage and transport. Direct iodination after amination, or vice versa, can cause side products. We engineered a stepwise route, controlling temperature and solvent carefully, to maximize yield and minimize hazardous waste—a concern often overlooked by bulk resellers.

Compared to 3-Amino-4-Bromopyridine, the iodinated version couples more smoothly, particularly with sterically hindered partners, under milder catalytic conditions. This difference becomes critical in multi-step pharmaceutical synthesis, where process safety and scalability drive decision-making. Savings in time, catalyst load, and raw materials make it the preferred choice for us and our customers.

Supporting Regulatory and Analytical Demands

Today’s regulatory environment puts chemical origins under the microscope. Pharmaceutical and agrochemical project leaders have asked us for traceable, auditable process documentation. We deliver a full analytical package with each shipment. Advanced NMR (400 MHz), mass-spec, and Karl Fischer moisture testing data accompany certificates of analysis. Some years ago, a major client highlighted that out-of-spec melting points halted weeks of downstream work. We responded by initiating automated in-process checks and archiving all QC data for five years, ensuring reproducibility and facilitating regulatory submissions worldwide.

Storage stability doesn’t escape our attention either. The aforementioned client also taught us the risks of long shelf-life and variable warehouse conditions. We responded with robust packaging, inert-atmosphere sealing, and regular stability retesting on retained samples, based on real-world shipping scenarios.

Safety, Environment, and Responsible Manufacturing

As an original manufacturer, we never dismiss safety and environmental responsibilities. Handling iodine chemicals brings risks—reactive metal residues, possible iodine vapor emissions, and specialized waste streams. We’ve invested in closed handling systems and routine waste neutralization. Our facility operates under enforceable permits for air and effluent. Compared to supply chains with unclear sourcing, our transparent approach offers assurance to downstream EHS teams who must justify every raw material in their risk assessments.

Process improvements rarely stand still. A few years ago, as global iodine prices spiked, process chemists at our plant tested recycling protocols and alternative oxidants for the iodination step. Adoption of more benign solvents and reuse of spent iodine extracts allowed us to mitigate cost impacts without passing short-term volatility onto clients.

We recognize that an open dialogue with users leads to ongoing product evolution. A major agrochemical producer helped us identify packaging formats that cut down on single-use plastics, and we have now moved to recyclable containers wherever permitted. These incremental changes, often only visible to those involved at the ground level, improve both the environmental outcome and the usability of the product for bulk buyers and bench chemists alike.

Real-World Applications Backed by Case History

On-the-ground customer experience reveals the value of this molecule better than abstract chemical diagrams. A medicinal chemistry group working on CNS-active compounds leveraged the dual functional groups to quickly iterate through matched molecular pairs. They told us that substituting the bromine in 3-Amino-4-Bromopyridine for our iodinated analogue improved coupling yields by up to 30% in their hands. This reduced not only raw material cost but also the timeline to preclinical candidate nomination.

Another customer in the field of crop protection used 3-Amino-4-Iodopyridine to introduce a unique nitrogen-containing heterocycle, streamlining their pathway from bench to pilot plant. Feedback from these use cases flows directly into process adjustments. Our R&D department tracks returns and out-of-spec events, and we open direct feedback channels—not just sales hotlines, but real-time communications between plant chemists and those at the bench. This tradition, built over decades, ensures the product continually meets the shifting precision requirements of researchers.

Staying Ahead in Quality and Reliability

Solving recurring issues for clients means keeping a close eye on every unit operation. By listening to synthetic chemists and process engineers, we learned that crystal morphology affects weighing and dispensing accuracy in automated systems. Our in-process crystallization control leads to a consistent particle profile, allowing seamless transfer from sample weighing to full reactor scale.

Moisture acts as both friend and foe. Trace water enhances some couplings, yet excess impedes others. We adapted our final drying to deliver product within a tight moisture range, catering to customers with strict process validation requirements. As other suppliers sometimes batch product with broad moisture tolerance, we provide test data up front, removing uncertainty from the specification.

We do not operate as a faceless bulk supplier. Our plant chemists stay available for technical troubleshooting and custom solution development. Direct communication helps users integrate our product into newly validated protocols faster than using anonymous intermediaries.

The Distinct Value: Beyond Commodity Chemicals

Commodity suppliers often miss the fine-line differences that matter most in synthetic chemistry. We see that 3-Amino-4-Iodopyridine works as an enabler, propelling research and manufacturing teams past bottlenecks in process route scouting, lead optimization, and patent filing. Its unique substitution pattern outperforms simpler halopyridines and aminopyridines in several patented processes, including those targeting oncology and anti-infective agents.

This molecule stands up to scrutiny not because of glossy marketing, but due to its consistent performance and support from teams who synthesize and analyze it daily. Operational experience at our facility, from reactor loading and fume management to filtration and drying, shapes every lot we ship. This knowledge base transforms user feedback into tangible improvements in product quality, reliability, and traceability.

The story of 3-Amino-4-Iodopyridine reflects a broader truth in chemical manufacturing: progress doesn’t come from shortcuts. Attention to every stage—from precursor selection, through optimized synthesis, to packing and distribution—determines the value delivered to end-users building the next generation of pharmaceuticals and crop protection agents.

Final Thoughts: Experience Determines Outcomes

We’ve watched numerous scientists change direction mid-project, only to return to this product after realizing the difficulty in replicating the dual-functional handle elsewhere in the pyridine family. Experience at the plant level shows that true quality comes not just from meeting assay specifications, but from relentless focus on feedback, data-driven process adjustments, and a sense of partnership with those at the research or production bench.

As your own work evolves, the hidden differences behind a simple chemical name—its stability, reactivity, and documentation—shape outcomes at every development stage. In our experience, those who make the effort to understand, and continually improve, the details of their chemical building blocks, find better, faster, and more sustainable results. Through direct engagement, technical expertise, and a relentless drive for continuous improvement, we help researchers, developers, and manufacturers push the boundaries of what’s possible using 3-Amino-4-Iodopyridine.